Philips and Merck partner to develop personalised fertility treatment

"Remote patient monitoring, cloud-based platform services and AI-enabled ultrasound diagnoses will be used to improve outcomes in fertility treatment.
Netherlands-based global health technology company, Royal Philips has announced a multi-year partnership with US science and technology company, Merck to develop digital solutions for personalised fertility treatment.
WHY IT MATTERS
According to the National Health Service, roughly one in seven couples in the UK will have trouble conceiving.
The platform will leverage advanced informatics and mobile, AI-enabled ultrasound diagnostics, to better inform patients and clinicians about the choice and timing of fertility treatment to maximise the chances of conception.
THE LARGER CONTEXT
Investors have gained an increased interest for femtech and fertility apps recently as remote monitoring models have picked up and proved invaluable during the pandemic.
An example of this growth in interest is the UK-based digital fertility employee benefits company Fertifa achieved the closing of its £1 million financing round last year.
Virtual fertility clinic Apricity launched an online fertility predictor tool designed to predict a woman's chances of conceiving naturally based on information input on their lifestyle choices. ..." Lire la suite